Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Activation of the Aryl Hydrocarbon Receptor-Cytochrome P450 1A1 Axis Mediates the Selective Cytotoxicity of 2‑Phenyl-Imidazo[1,2‑<i>a</i>]Pyridine Derivatives in Triple-Negative Breast Cancer Cells.

ACS pharmacology & translational science·2026
Same author

OpenStats: how to combine statistics and research data management (RDM) to leverage efficient scientific data analysis by guided statistics.

Journal of cheminformatics·2026
Same author

Expression of Axonal Transport Proteins in Dopaminergic Neurons of the Substantia Nigra in Mouse Models of Preclinical and Clinical Stages of Parkinson's Disease.

International journal of molecular sciences·2026
Same author

Ultra-High-Throughput Discovery of Multifunctional Polyphenolic Coatings on Droplet Microarrays.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Distinct 2-phenylimidazo[1,2-<i>a</i>]pyridine derivatives that inhibit breast cancer cell proliferation identified as AHR ligands.

iScience·2026
Same author

Clinical characteristics and five-year outcomes in a prospective Russian real-world heart failure cohort.

Vascular pharmacology·2026

Related Experiment Video

Updated: Sep 4, 2025

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.8K

Droplet Microarray as a Powerful Platform for Seeking New Antibiotics Against Multidrug-Resistant Bacteria.

Wenxi Lei1, Anke Deckers1, Charlotte Luchena1

  • 1Institute of Biological and Chemical Systems - Functional Molecular Systems, Karlsruhe Institute of Technology, Hermann-von-Helmholtz Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.

Advanced Biology
|July 17, 2022
PubMed
Summary

A new droplet microarray system efficiently screens thousands of compounds for antibacterial activity against resistant bacteria like MRSA. This high-throughput method identifies potential new antibiotics to combat public health threats.

Keywords:
Klebsiella pneumoniaeMRSAantibacterialhigh throughput screeningmicroarrays

More Related Videos

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

11.0K
Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
06:11

Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip

Published on: March 29, 2024

1.9K

Related Experiment Videos

Last Updated: Sep 4, 2025

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.8K
Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

11.0K
Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
06:11

Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip

Published on: March 29, 2024

1.9K

Area of Science:

  • Microbiology and Drug Discovery
  • Biotechnology and Bioengineering
  • Chemical Biology

Background:

  • Multidrug-resistant (MDR) bacteria pose a significant global health risk.
  • Effective screening systems are crucial for discovering novel antibacterial agents.
  • Carbapenem-resistant Klebsiella pneumoniae and methicillin-resistant Staphylococcus aureus (MRSA) are key pathogens of concern.

Purpose of the Study:

  • To develop and validate a highly miniaturized droplet microarray (DMA) based high-throughput screening system.
  • To screen a library of over 2000 compounds for antimicrobial activity.
  • To identify novel compounds effective against MDR bacteria.

Main Methods:

  • Fabrication of a droplet microarray with hydrophilic spots and superhydrophobic borders for nanoliter droplet generation.
  • High-throughput screening of 2000+ compounds against carbapenem-resistant K. pneumoniae and MRSA.
  • Development of a colorimetric viability assay for rapid, single-step detection of bacterial growth inhibition.
  • Validation of hit compounds using minimum inhibitory concentration (MIC) assays.

Main Results:

  • Successful establishment of a DMA-based high-throughput screening system.
  • Identification of six hit compounds with antimicrobial properties.
  • Hit compounds include coumarins and simplified estrogen analogs.
  • Validated antibacterial effects of identified compounds against target MDR bacteria.

Conclusions:

  • The DMA-based system is effective for high-throughput screening of potential antibiotics.
  • This approach facilitates the discovery of novel antibacterial agents from synthetic libraries.
  • The developed system offers a promising avenue for combating MDR bacterial infections.
  • Potential for new therapeutic strategies against critical bacterial pathogens.